← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-027 | 73198-027-03 | Phentolamine Mesylate; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1213 | 1213 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5078 | 26436-5078-1 | Potassium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1213 | 1213 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Niacinamide; Dexpanthenol; Pyridoxine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1213 | 1213 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-811 | 71170-811-02 | Semaglutide | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-122 | 73198-122-30 | Sodium Tetradecyl Sulfate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1214 | 1214 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Fent 2 mcg/mlBup 0.0625% PF 250ml NS IVB | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-5 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6065 | 71286-6065-3 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-676 | 70324-676-01 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-781 | 70004-781-40 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1214 | 1214 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nandrolone Decanoate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1214 | 1214 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nandrolone Decanoate | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8210 | 71266-8210-5 | Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6009 | 71286-6009-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-021 | 73198-021-05 | Phenylephrine | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1214 | 1214 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1214 | 1214 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Potassium Chloride | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-452 | 70092-452-44 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-155 | 63037-155-25 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-495 | 71170-495-05 | Semaglutide | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1214 | 1214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1591 | 72934-1591-2 | Spironolactone; Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1215 | 1215 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2535 | 72934-2535-2 | Nolira | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1215 | 1215 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-926 | 70324-926-01 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-771 | 70004-771-40 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8210 | 71266-8210-1 | Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6058 | 71285-6058-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1215 | 1215 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1215 | 1215 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-127 | 73177-127-05 | Potassium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-9 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-156 | 63037-156-25 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-821 | 71170-821-01 | Semaglutide | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1215 | 1215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1624 | 72934-1624-2 | Spironolactone; Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1216 | 1216 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6044 | 72196-6044-1 | Oxytocin 30units added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1216 | 1216 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1216 | 1216 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1216 | 1216 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1216 | 1216 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-771 | 70004-771-44 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1216 | 1216 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-03 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1216 | 1216 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1549 | 5446-1549-05 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1216 | 1216 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1216 | 1216 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7025 | 71285-7025-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1216 | 1216 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1216 | 1216 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5601 | 26436-5601-5 | Phentolamine Mesylate; Papaverine Hydrochloride; Alprostadil | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1216 | 1216 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Potassium Chloride | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1216 | 1216 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-1 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1216 | 1216 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1216 | 1216 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5424 | 26436-5424-2 | Sermorelin Acetate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1216 | 1216 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2591 | 72934-2591-2 | Spironolactone; Dapsone; Niacinamide | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1217 | 1217 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-140 | 73198-140-03 | PGE-2 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1217 | 1217 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6057 | 72196-6057-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1217 | 1217 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-787 | 76154-787-75 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1217 | 1217 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1217 | 1217 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8078 | 71285-8078-1 | Potassium Acetate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1217 | 1217 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-687 | 69194-687-01 | Povidone-Iodine | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1217 | 1217 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9005 | 71266-9005-5 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1217 | 1217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1218 | 1218 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-10 | T-101 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1218 | 1218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1218 | 1218 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-33 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1218 | 1218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1218 | 1218 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6056 | 72196-6056-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1218 | 1218 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6065 | 72196-6065-1 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1218 | 1218 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1218 | 1218 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6429 | 60652-6429-1 | Potassium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1218 | 1218 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-008 | 71506-008-58 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1218 | 1218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1218 | 1218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1218 | 1218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Povidone-Iodine | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1218 | 1218 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-099 | 71506-099-05 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1218 | 1218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1218 | 1218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1218 | 1218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1219 | 1219 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-018 | 72055-018-01 | Oxytocin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1219 | 1219 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-05 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1219 | 1219 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8096 | 72196-8096-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-103 | 71449-103-11 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-127 | 73177-127-06 | Potassium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-808 | 70004-808-40 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1219 | 1219 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1219 | 1219 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4538 | 61141-4538-4 | Povidone-Iodine | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-073 | 70092-073-44 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1219 | 1219 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-099 | 71506-099-05 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1219 | 1219 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1219 | 1219 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1220 | 1220 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1541 | 72934-1541-2 | Weleris | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1220 | 1220 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1373 | 61141-1373-5 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1220 | 1220 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-35 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1220 | 1220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1220 | 1220 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8097 | 72196-8097-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1220 | 1220 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1220 | 1220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1220 | 1220 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-127 | 73177-127-05 | Potassium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1220 | 1220 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-15 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1220 | 1220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1220 | 1220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1220 | 1220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Povidone-Iodine | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1220 | 1220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1220 | 1220 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-159 | 73177-159-03 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1220 | 1220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1220 | 1220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1221 | 1221 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6023 | 26436-6023-3 | TESTOSTERONE 15% | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1221 | 1221 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-009 | 71449-009-07 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1221 | 1221 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1221 | 1221 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-504 | 69374-504-25 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1221 | 1221 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1221 | 1221 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-830 | 33216-830-03 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1221 | 1221 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1221 | 1221 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0218 | 71285-0218-1 | Potassium Chloride; Dextrose Monohydrate; Calcium Chloride; Sodium Chloride; Magnesium Sulfate Heptahydrate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1221 | 1221 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-825 | 70004-825-40 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1221 | 1221 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1221 | 1221 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1221 | 1221 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5465 | 26436-5465-3 | Prasterone; Estriol | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1221 | 1221 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1221 | 1221 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-159 | 73177-159-02 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1221 | 1221 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1221 | 1221 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1222 | 1222 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0432 | 72196-0432-1 | Trophamine 4.5%/Dextrose 10% With Heparin 125 units 250ml in 250ml bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-009 | 71449-009-05 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1222 | 1222 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-533 | 69374-533-25 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8095 | 71285-8095-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1222 | 1222 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-03 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1222 | 1222 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Povidone-Iodine | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6092 | 72196-6092-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1222 | 1222 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1222 | 1222 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0630 | 70168-0630-1 | Prasterone; Testosterone Cypionate | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-170 | 82396-170-10 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6010 | 72196-6010-1 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1222 | 1222 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1222 | 1222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-013 | 72055-013-01 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1223 | 1223 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2100 | 70168-2100-1 | E2 50mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1223 | 1223 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-009 | 71449-009-11 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1223 | 1223 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1223 | 1223 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-528 | 69374-528-25 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1223 | 1223 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8096 | 71285-8096-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1223 | 1223 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1223 | 1223 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1223 | 1223 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Povidone-Iodine | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1223 | 1223 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-806 | 70004-806-40 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1223 | 1223 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1223 | 1223 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1223 | 1223 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1223 | 1223 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-924 | 69374-924-05 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1223 | 1223 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-170 | 82396-170-10 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1223 | 1223 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1223 | 1223 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-001 | 72055-001-01 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1224 | 1224 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-1 | Hydromorphone HCl | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-05 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-922 | 69374-922-03 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1224 | 1224 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1509 | 5446-1509-01 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-922 | 69374-922-03 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4538 | 61141-4538-4 | Povidone-Iodine | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6009 | 72196-6009-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1224 | 1224 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1224 | 1224 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1224 | 1224 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-510 | 65302-510-05 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-073 | 70092-073-44 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0001 | 26436-0001-1 | Sildenafil Citrate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1224 | 1224 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1225 | 1225 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-2243 | 72682-2243-1 | Ascorbic Acid (PF/Non-Corn) 500 mg/ml 10mL Refrig | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-03 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-942 | 69374-942-04 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1225 | 1225 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-004 | 71506-004-50 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-942 | 69374-942-04 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0630 | 70168-0630-1 | Prasterone; Testosterone Cypionate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1225 | 1225 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1225 | 1225 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1225 | 1225 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-155 | 63037-155-25 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-4001 | 73013-4001-2 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5591 | 26436-5591-1 | Sildenafil Citrate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1225 | 1225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-020 | 71170-020-05 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1226 | 1226 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-364 | 73693-364-01 | TESTOSTERONE, TRIAMCINOLONE 200MG, 40MCG | 2025-1 | valid | 0 | 2026-09-18 |